A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

Overview of attention for article published in Neurology, March 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 2 X users

patent: 34 patents

Readers on

mendeley: 72 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 548 followers.

Natalizumab is a humanized monoclonal antibody against the alpha 4 integrin subunit http://t.co/EmHew6U9 #MDLiveIBD #ACG2012

Natalizumab is a humanized monoclonal antibody against the alpha 4 integrin subunit http://t.co/EmHew6U9 #MDLiveIBD #ACG2012

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.